Hi Abloke, IMHO it's probably because they don't want you to notice.
The way I see it is there can only really be two plausible reasons for the departure of a CMO from a medical device company during a period where a critical decision is due from a regulator/notified body. The first is he left for a better opportunity; that doesn't say much for the internal confidence around BSI's decision on CE mark, or the company's hopes for success in the 'near-term' and a sky rocketing share price. The second is he was invited to leave; this one is more concerning because he would have been very involved in the company's dealing with BSI over the last 4-5 years. That's a long time to influence a submission!
Just my take. DYOR
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.000(0.00%) |
Mkt cap ! $14.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6796 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 50 | 1 |
View Market Depth
| Last trade - 09.45am 25/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |
Day chart unavailable